Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Carotid Revascularization Endarterectomy Versus Stenting Trial

Study:

Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)

Rationale:

n/a

Purpose:

The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of stent-assisted carotid angioplasty (CAS) to the traditional and accepted surgical approach of carotid endarterectomy (CEA) for the treatment of carotid artery stenosis to prevent recurrent strokes in those patients who have had a TIA (transient ischemic attack) or a mild stroke within the past 6 months (symptomatic) and in those patients who have not had any symptoms within the past 6 months (asymptomatic).

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Atherosclerosis
Stroke
Carotid Stenosis
Cerebral Infarction
Myocardial Infarction
Procedure: Carotid Endarterectomy (CEA)
Device: Carotid Artery Stenting (CAS)
Phase 3

Verified by University of Medicine and Dentistry New Jersey September, 2013

Sponsored by: University of Medicine and Dentistry New Jersey
Information provided by: Rutgers, The State University of New Jersey
ClinicalTrials.gov identifier: NCT00004732

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Cleveland Clinic
Cleveland, Ohio 44195
United States

Thomas G. Brott, M.D.., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site